Trade

with

ZELTIQ Aesthetics Inc
(NASDAQ: ZLTQ)
AdChoices
22.98
+0.48
+2.13%
After Hours :
22.98
0.00
0.00%

Open

23.34

Previous Close

22.50

Volume (Avg)

274.88k (727.25k)

Day's Range

22.47-23.34

52Wk Range

8.74-27.04

Market Cap.

862.34M

Dividend Rate ( Yield )

-

Beta

0.09

Shares Outstanding

37.53M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 111.63M

    • Net Income

    • -19.30M

    • Market Cap.

    • 862.34M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -8.92

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.09

    • Forward P/E

    • -416.67

    • Price/Sales

    • 5.91

    • Price/Book Value

    • 14.12

    • Price/Cash flow

    • -104.17

      • EBITDA

      • -17.62M

      • Return on Capital %

      • -15.09

      • Return on Equity %

      • -20.35

      • Return on Assets %

      • -15.09

      • Book Value/Share

      • 1.63

      • Shares Outstanding

      • 37.53M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 27.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.04

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 78.70

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 70.95

            • 64.08

            • Pre-Tax Margin

            • -8.85

            • 15.19

            • Net Profit Margin

            • -8.92

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 41.60

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -247.10

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -301.60

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 2.87

              • 2.55

              • Quick Ratio

              • 2.06

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.42

              • 1.86

              • Book Value/Share

              • 1.63

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -66.23

                • 34.01

                • P/E Ratio 5-Year High

                • -78.03

                • 224.03

                • P/E Ratio 5-Year Low

                • -9.23

                • 60.23

                • Price/Sales Ratio

                • 5.91

                • 3.17

                • Price/Book Value

                • 14.12

                • 3.20

                • Price/Cash Flow Ratio

                • -104.17

                • 18.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -20.35

                        (-)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -15.09

                        (-98.70)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -20.35

                        (-)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 2.96

                      • 2.77

                      • Asset Turnover

                      • 1.69

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -19.35M
                      Operating Margin
                      -17.33
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -104.17
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      69.15%

                      Mutual Fund Ownership

                      45.09%

                      Float

                      77.60%

                      5% / Insider Ownership

                      3.62%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • VA CollegeAmerica Small Cap World

                      •  

                        3,002,044

                      • 45.03

                      • 8.00

                      • Lord Abbett Developing Growth Fund

                      •  

                        1,894,378

                      • 10.71

                      • 5.05

                      • Fidelity® Select Health Care Portfolio

                      •  

                        1,280,000

                      • 0.00

                      • 3.41

                      • RS Small Cap Growth Fund

                      •  

                        898,000

                      • 26.16

                      • 2.39

                      • Vanguard VIF Small Comp Gr

                      •  

                        862,664

                      • 0.00

                      • 2.30

                      • Fidelity® Select Medical Equip & Systems

                      •  

                        650,000

                      • 0.00

                      • 1.73

                      • Vanguard Total Stock Mkt Idx

                      •  

                        454,365

                      • 0.00

                      • 1.21

                      • iShares Russell 2000 (AU)

                      •  

                        453,531

                      • -1.02

                      • 1.20

                      • Deutsche Global Small Cap Fund

                      •  

                        450,377

                      • 3.20

                      • 1.20

                      • Janus Venture Fund

                      •  

                        408,281

                      • 0.00

                      • 1.09

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Advanced Technology Ventures

                      •  

                        3,876,221

                      • -50.94%

                      • 10.47

                      • Venrock Management V LLC

                      •  

                        3,120,326

                      • -36.64%

                      • 8.42

                      • Lord, Abbett & Co LLC

                      •  

                        3,042,191

                      • +21.47%

                      • 8.11

                      • Fidelity Management and Research Company

                      •  

                        2,915,900

                      • +15.49%

                      • 7.77

                      • Aisling Capital Partners III LLC

                      •  

                        2,597,742

                      • -27.80%

                      • 7.01

                      • Capital World Investors

                      •  

                        2,070,000

                      • +59.19%

                      • 5.52

                      • Eminence Capital LLC

                      •  

                        1,862,309

                      • +150.65%

                      • 4.96

                      • PointState Capital LP

                      •  

                        1,665,000

                      • 0.00%

                      • 4.44

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      ZELTIQ Aesthetics Inc was incorporated in the state of Delaware on March 22, 2005. In August 2011, the Company incorporated ZELTIQ Limited as a wholly-owned subsidiary in the United Kingdom to serve as its sales office for direct sal...morees in Europe. The Company was founded to develop and commercialize a non-invasive product for the selective reduction of fat. On October 24, 2011, the Company completed its initial public offering, or IPO, of 8,050,000 shares of common stock, of which 7,743,000 shares were sold by the Company and 307,000 shares were sold by existing stockholders. The Company generates revenue from sales of CoolSculpting system and from sales of consumables to its customers. Its geographical region includes North America and International. The Company’s first commercial product, the CoolS...moreculpting system, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. The Company manufactures and distributes its CoolSculpting system, including procedure packs, at its Dublin facility. The Livermore facility is used primarily for raw material storage. Through 2012 and the beginning of 2013, the Company has utilized OnCore Manufacturing LLC to manufacture and supply CoolSculpting system. ZELTIQ®, CoolSculpting®, and Company’s logo are registered trademarks in the United States and in certain foreign countries. The design, development, manufacture, testing and sale of products are subject to regulation by governmental authorities, mainly FDA, and corresponding state and foreign regulatory agencies.lessless

                      Key People

                      Mr. Mark J. Foley

                      CEO/Director/President

                      Mr. Patrick Williams

                      CFO/Chief Accounting Officer/Senior VP

                      Carl Lamm

                      Vice President, Divisional

                      Kevin C. O'Boyle

                      Director

                      Dr. Bryan E. Roberts,PhD

                      Director

                      • ZELTIQ Aesthetics Inc

                      • 4698 Willow Road

                      • Pleasanton, CA 94588

                      • USA.Map

                      • Phone: +1 925 474-2500

                      • Fax: +1 925 474-2599

                      • coolsculpting.com

                      Incorporated

                      2005

                      Employees

                      357

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: